Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology
- PMID: 37775522
- PMCID: PMC10541862
- DOI: 10.1038/s41746-023-00923-7
Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology
Abstract
Hundreds of randomized controlled trials (RCTs) have tested the efficacy of mobile health (mHealth) tools for a wide range of mental and behavioral health outcomes. These RCTs have used a variety of control condition types which dramatically influence the scientific inferences that can be drawn from a given study. Unfortunately, nomenclature across mHealth RCTs is inconsistent and meta-analyses commonly combine control conditions that differ in potentially important ways. We propose a typology of control condition types in mHealth RCTs. We define 11 control condition types, discuss key dimensions on which they differ, provide a decision tree for selecting and identifying types, and describe the scientific inferences each comparison allows. We propose a five-tier comparison strength gradation along with four simplified categorization schemes. Lastly, we discuss unresolved definitional, ethical, and meta-analytic issues related to the categorization of control conditions in mHealth RCTs.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Data Missing Not at Random in Mobile Health Research: Assessment of the Problem and a Case for Sensitivity Analyses.J Med Internet Res. 2021 Jun 15;23(6):e26749. doi: 10.2196/26749. J Med Internet Res. 2021. PMID: 34128810 Free PMC article.
-
Let's decide what would be convincing, conduct randomized trials with rigorous comparison conditions, and report tests of moderation and publication bias in meta-analyses.PLOS Digit Health. 2022;1(11):e0000127. doi: 10.1371/journal.pdig.0000127. Epub 2022 Nov 3. PLOS Digit Health. 2022. PMID: 36484072 Free PMC article.
-
Efficacy, Safety, and Evaluation Criteria of mHealth Interventions for Depression: Systematic Review.JMIR Ment Health. 2023 Sep 27;10:e46877. doi: 10.2196/46877. JMIR Ment Health. 2023. PMID: 37756042 Free PMC article. Review.
-
The Comparative Effectiveness of Mobile Phone Interventions in Improving Health Outcomes: Meta-Analytic Review.JMIR Mhealth Uhealth. 2019 Apr 3;7(4):e11244. doi: 10.2196/11244. JMIR Mhealth Uhealth. 2019. PMID: 30942695 Free PMC article.
Cited by
-
Therapist-guided, Internet-delivered cognitive behaviour therapy for adolescents with body dysmorphic disorder: A feasibility trial with long-term follow-up.Internet Interv. 2023 Nov 16;34:100688. doi: 10.1016/j.invent.2023.100688. eCollection 2023 Dec. Internet Interv. 2023. PMID: 38034863 Free PMC article.
-
Digital interventions in mental health: An overview and future perspectives.Internet Interv. 2025 Apr 2;40:100824. doi: 10.1016/j.invent.2025.100824. eCollection 2025 Jun. Internet Interv. 2025. PMID: 40330743 Free PMC article. Review.
-
Methodological Challenges in Randomized Controlled Trials of mHealth Interventions: Cross-Sectional Survey Study and Consensus-Based Recommendations.J Med Internet Res. 2024 Dec 19;26:e53187. doi: 10.2196/53187. J Med Internet Res. 2024. PMID: 39700488 Free PMC article.
-
Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs.World Psychiatry. 2024 Oct;23(3):364-386. doi: 10.1002/wps.21230. World Psychiatry. 2024. PMID: 39279422 Free PMC article.
-
Efficacy of a smartphone-based Cognitive Bias Modification program for emotion regulation: A randomized-controlled crossover trial.Internet Interv. 2024 Feb 9;35:100719. doi: 10.1016/j.invent.2024.100719. eCollection 2024 Mar. Internet Interv. 2024. PMID: 38370286 Free PMC article.
References
-
- WHO. mHealth Use of Appropriate Digital Technologies for Public Health. 10.1371/journal.pmed.1001362 (2018).
-
- FDA. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs. https://www.fda.gov/news-events/press-announcements/fda-clears-mobile-me... (2022).
-
- FDA. FDA permits marketing of first game-based digital therapeutic to improve attention function in children with ADHD. https://www.fda.gov/news-events/press-announcements/fda-permits-marketin... (2022).
-
- TBRC. The mobile healthcare market is expected to reach $250. https://www.globenewswire.com/news-release/2022/03/29/2412162/0/en/The-M... (2022).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources